Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease - Wikidata - wikimedia - TriplyDB

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

http://www.wikidata.org/entity/Q24601951

about

Enteric microbiome metabolites correlate with response to simvastatin treatment A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment Placing epidemiological results in the context of multiplicity and typical correlations of exposures The human microbiome: our second genome Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis Exposure science and the exposome: an opportunity for coherence in the environmental health sciences From hepatoprotection models to new therapeutic modalities for treating liver diseases: a personal perspective The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease The gut microbiome in human immunodeficiency virus infection Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis A healthy gastrointestinal microbiome is dependent on dietary diversity Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation Probiotics and blood pressure: current insights Probiotics in prevention and treatment of obesity: a critical view Making the Leap from Research Laboratory to Clinic: Challenges and Opportunities for Next-Generation Sequencing in Infectious Disease Diagnostics The enteric microbiome in hepatobiliary health and disease Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections Bioactive Egg Components and Inflammation Xenobiotics: Interaction with the Intestinal Microflora Metagenomic surveys of gut microbiota Increased Intake of Foods with High Nutrient Density Can Help to Break the Intergenerational Cycle of Malnutrition and Obesity Role of gut microbiota in the modulation of atherosclerosis-associated immune response Gut microbes and host physiology: what happens when you host billions of guests?Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis Metabolomics: A Tool Ahead for Understanding Molecular Mechanisms of Drugs and Diseases The contributory role of gut microbiota in cardiovascular disease Microbiome analysis - from technical advances to biological relevance Assessing the human gut microbiota in metabolic diseases Archaea in and on the Human Body: Health Implications and Future Directions Approaches to uremia A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion Identifying novel biomarkers for cardiovascular disease risk prediction Investigating potential mechanisms of obesity by metabolomics

P2860

Q21135141-DD83D8DD-FAB8-42E0-ADB7-7CF5449E5C88 Q21144941-EF687424-73A0-4179-8835-899E0B310536 Q21561017-E4F871AA-5626-4F2A-AD03-D31C70E57676 Q24289033-D3C25F12-63EB-4E75-B0A4-D3AEEF3FF3C9 Q24601696-2710531F-9D1E-4E2D-892F-66627AB719AA Q24603491-D8293020-DFEA-40D8-9D29-27C8A126C7BD Q24629045-5FE12FCA-65AC-4CD0-A4D2-9F395960502F Q24633688-A2C69364-ABEE-4FD6-B946-7683C3032AE7 Q26738626-C7169C57-940A-4130-B64F-6D5EE1C44D4B Q26739993-044AF4E7-67E3-4DFC-B082-0DB6D39A91DE Q26741117-E331F669-DBB8-4670-9E45-8166944A79E8 Q26743543-152B6282-31DF-47FD-B96F-18F990413A10 Q26747593-DA9036E2-66D8-44C4-ABBC-12280B3BAEC5 Q26750607-DF0E186A-4870-494C-8FD3-1A3B9B7CEE23 Q26750865-0116EEC3-93A0-4C6F-9D31-D63D74B30AB1 Q26751203-65B49420-4B98-431B-B321-DECBE1677606 Q26752979-E0288CDA-4A32-48D4-BD02-61299F480FB4 Q26753047-4F61BE56-475B-4EF0-A3B6-7C72246304E3 Q26765740-0F6994CA-24E6-4646-9485-6E38FBA258A0 Q26767248-E8DC1C43-DA87-4D6A-891D-C1B9312A8785 Q26768518-3C9D5C2A-A5A8-49FE-906E-51575199779C Q26773525-6DAD39FE-B959-45F8-998F-A1808E3D01A1 Q26777426-6A29930B-5614-443A-8CD4-F9A69F703B32 Q26782662-2828BCB5-355B-49F1-BAB8-2AD062BE387B Q26782731-1E624722-BEC1-4DEB-A38C-060FF1D36481 Q26795702-79E8B7C1-435F-448F-BD8A-718F1AFAA455 Q26799820-5E485472-981E-40FC-BEE6-7710AECA258D Q26801379-8C31C676-6D6D-4A04-A892-B9399416CC41 Q26801649-A97B7282-7821-4441-8981-F6FA3C4A7209 Q26822836-87C0ED3A-A2FC-455D-8A4D-06B981B5742E Q26823198-9675721F-C4E9-4506-A5A8-A20ED5B1EC77 Q26827107-121335A3-4255-4798-8F87-F25ECD47425E Q26830828-4DF4B091-4051-4E96-AC45-414B9D2DD56B Q26849411-BC435B47-DB73-4A20-9235-E7B183EA21B8 Q26860785-F009F488-B73D-4A95-93DB-15E447AF5CE5 Q26863524-0C99FC6A-A107-4600-8A50-9176F11251BB Q26864807-9842DE4F-A034-4851-8E9D-EF80F169DD8E Q26865600-EFFBEB61-55F1-48B6-BDB2-E1391002B266 Q26865722-36BC70F9-38BF-4DDC-96F2-772EB2DF9410 Q26865774-57A43DB1-C1FD-4E9F-8C4E-30E155870F98

P2860

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

http://www.wikidata.org/entity/Q24601951

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@ast

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@en

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@nl

type

label

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@ast

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@en

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@nl

prefLabel

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@ast

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@en

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@nl

P1433

Q24601951-578E7C1D-FF29-4A9E-AFE6-478BB4ED00D8

P1476

Q24601951-F0CA718D-ED4D-4083-B2CA-6E90251221DB

P2093

Q24601951-064B3CD3-501C-48AD-BED7-0FAC99973FBB

Q24601951-0961D2CD-02CC-467B-B1E0-9731E1B4077E

Q24601951-0A833A99-91CC-4D2F-AF6D-CF1D8E350802

Q24601951-1EEC0A05-9CA6-49E2-BAA4-17806DECDE37

Q24601951-214CA3B7-ADA4-4AF6-BD15-27110FCFBE7F

Q24601951-24F1638F-8AA3-4D2F-9362-70350337A4D7

Q24601951-400C628F-C1A5-41B3-B641-CA5069E29D4F

Q24601951-5C5E1BF4-46E2-48BB-B3B4-97761E708C66

Q24601951-5EE313AB-6901-434F-8736-DAED1899A007

Q24601951-75175B76-1BC6-4B76-B342-7E46ED979AC4

P2860

Q24601951-0604DBDA-AEDF-405C-AC4E-F5C68B5CACB1

Q24601951-1560EAB7-D179-4C3E-888D-5893C560186E

Q24601951-1AC52006-7DEA-4B2D-9F2D-716DBD878EC3

Q24601951-1CB40267-79DC-493F-BAB1-65B402C1AE07

Q24601951-1D410083-ED8F-454F-9220-38548D34AC62

Q24601951-1F1D5A1E-5947-416D-A5B7-20A3FB82C860

Q24601951-2172DDCD-371A-4082-8A63-EB3E3A53C1AB

Q24601951-2583F0C1-2751-4C17-A250-5BDFA5A4EE36

Q24601951-2A0B2822-3701-4845-BD44-4A45DC429F03

Q24601951-2AD54697-5F0B-481F-B2D4-A2E338D0CF3F

P2888

Q24601951-26813C13-14EC-47BA-BF17-B6C6BECCEB70

P304

Q24601951-056E200E-7FD3-4DB3-9160-A65112CAB2E0

P31

Q24601951-08A03C3C-98A1-4988-BE7F-820745985A6A

P3181

Q24601951-EAD1D026-3329-4CFC-8590-71D6EAEA2F28

P356

Q24601951-352C92DE-3445-4044-9189-34D1D2CD1DCE

P407

Q24601951-775A3CFF-84B5-4347-8AB9-EF08BB13FECD

P433

Q24601951-D6B3C29E-1405-4816-8C1C-1CC355A169AF

P478

Q24601951-F6DC6475-5367-4EF9-978E-23658A66723E

P50

Q24601951-13166FDF-6E05-44B3-BEDF-EB01D0CFF917

Q24601951-666D5F96-0CC2-4D07-9EFE-E433E4BAC283

Q24601951-97AE8331-CD1D-4C2C-8F63-2A259F894320

Q24601951-DAED2A5F-9FDA-478D-AF26-185AFAA86D59

P577

Q24601951-5F81C738-164A-42F8-BF3E-86C22E1BD27C

P5875

Q24601951-3CFDE05B-2958-4AF0-A243-252128E67D9C

P6179

Q24601951-E89AAD3B-401F-4DEF-B666-3F7F08E6DAC5

P698

Q24601951-7D4FC515-856C-4E62-B48F-A75E6F12023F

P921

Q24601951-59e9827a-476d-13dd-8172-d678117377d8

Q24601951-f9eabdd4-4701-cafa-1f1f-f243e8ad877f

P932

Q24601951-1734F90B-C23C-4E7E-B629-DF7D2D0EEF47

P3181

P356

P1433

P1476

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

@en

P2093

Ariel E Feldstein

http://www.w3.org/2001/XMLSchema#string

Brandon Dugar

http://www.w3.org/2001/XMLSchema#string

Brian J Bennett

http://www.w3.org/2001/XMLSchema#string

Earl B Britt

http://www.w3.org/2001/XMLSchema#string

Elizabeth Klipfell

http://www.w3.org/2001/XMLSchema#string

Hooman Allayee

http://www.w3.org/2001/XMLSchema#string

Joseph A DiDonato

http://www.w3.org/2001/XMLSchema#string

Phil Schauer

http://www.w3.org/2001/XMLSchema#string

Robert Koeth

http://www.w3.org/2001/XMLSchema#string

Stanley L Hazen

http://www.w3.org/2001/XMLSchema#string

P2860

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

Diversity of the human intestinal microbial flora

Genetic and genomic analysis of a fat mass trait with complex inheritance reveals marked sex specificity.

A simple method for the isolation and purification of total lipides from animal tissues

An obesity-associated gut microbiome with increased capacity for energy harvest

Microbial ecology: human gut microbes associated with obesity

Host-bacterial mutualism in the human intestine

The freeze-avoidance response of smelt Osmerus mordax: initiation and subsequent suppression of glycerol, trimethylamine oxide and urea accumulation

Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome

Quantitative analysis of FMO gene mRNA levels in human tissues

P2888

P304

57-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

199267

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE09922

http://www.w3.org/2001/XMLSchema#string

P407

P433

7341

http://www.w3.org/2001/XMLSchema#string

P478

472

http://www.w3.org/2001/XMLSchema#string

P50

Bruce S. Levison

Aldons Jake Lusis

Jonathan D Smith

P577

2011-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51034413

http://www.w3.org/2001/XMLSchema#string

P6179

1043309820

http://www.w3.org/2001/XMLSchema#string

P698

21475195

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

phosphatidylcholines

P932

3086762

http://www.w3.org/2001/XMLSchema#string